Skip to content

Richard B Rothman

46 papers in the library · 3,268 citations · publishing 1990-2019

Papers

Sort Most recent Most cited

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

Psychopharmacology March 15, 2006 Michael H. Baumann, Xiaoying Wang, Richard B Rothman 269 citations

RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA) is a widely abused illicit drug. In animals, high-dose administration of MDMA produces deficits in serotonin (5-HT) neurons (e.g., depletion of forebrain 5-HT) that have been interpreted as neurotoxicity. Whether such 5-HT deficits reflect neuronal damage is a matter of ongoing debate. OBJECTIVE: The present paper reviews four specific issues...

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.

Journal of Natural Products 2006 Wayne W Harding, Matthew Schmidt, Kevin Tidgewell et al. 59 citations

Salvinorin A (1) is a hallucinogenic neoclerodane diterpene isolated from the widely available psychoactive plant Salvia divinorum and is the first example of a non-nitrogenous opioid receptor ligand. At present, there is little information available as to why this compound is selective for kappa opioid receptors. One approach to better understanding the mode of binding of 1 at kappa receptors...

DOI: 10.1021/np050398i (opens in new tab) Full text (opens in new tab) Salvinorin a research Unique hallucinogen Compound 10a Neoclerodane diterpene +5

Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.

Journal of Pharmacology and Experimental Therapeutics January 2006 William A Carlezon, Cécile Béguin, Jennifer A DiNieri et al.

Endogenous opioids seem to play a critical role in the regulation of mood states. For example, there is accumulating evidence that stimulation of kappa-opioid receptors, upon which the endogenous opioid dynorphin acts, can produce depressive-like behaviors in laboratory animals. Here we examined whether systemic administration of salvinorin A (SalvA), a potent and highly selective kappa-opioid...

Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.

Journal of Medicinal Chemistry July 28, 2005 Wayne W Harding, Kevin Tidgewell, Nathan Byrd et al.

Structural modification of salvinorin A, the active component of Salvia divinorum, has resulted in the synthesis of novel neoclerodane diterpenes with opioid receptor affinity and activity. We report in this study a nonnitrogenous neoclerodane diterpene with mu opioid receptor affinity (13) that is an agonist at mu opioid receptors. This represents the identification of a novel structural class...

Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.

Organic Letters July 7, 2005 Wayne W Harding, Kevin Tidgewell, Matthew Schmidt et al.

[reaction: see text] Two new neoclerodane diterpenes, salvinicins A (4) and B (5), were isolated from the dried leaves of Salvia divinorum. The structures of these compounds were elucidated by spectroscopic techniques, including (1)H and (13)C NMR, NOESY, HMQC, and HMBC. The absolute stereochemistry of these compounds was assigned on the basis of single-crystal X-ray crystallographic analysis...

Effects of “Legal X” Piperazine Analogs on Dopamine and Serotonin Release in Rat Brain

Annals of the New York Academy of Sciences October 1, 2004 Michael H. Baumann, Robert D. Clark, Allison G. Budzynski et al. 71 citations

3,4-Methylenedioxymethamphetamine (MDMA) is a popular illicit drug that evokes transporter-mediated release of serotonin (5-HT) and dopamine (DA) from nerve cells. Recently, drug users have ingested combinations of the piperazine analogs, 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP), in an attempt to mimic the subjective effects of MDMA. In the present study, we...

DOI: 10.1196/annals.1316.024 (opens in new tab) MDMA Microdialysis Piperazine Pharmacology +6

3,4‐methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein

Synapse July 14, 2004 Xiaoying Wang, Michael H. Baumann, Heng Xu et al. 101 citations

Abstract Previous experiments conducted in this laboratory showed that administration of high‐dose D‐fenfluramine (D‐FEN) and p‐chloroamphetamine (PCA) decreased 5‐HT transporter (SERT) binding and tissue 5‐HT by 30–60% in caudate and whole brain tissue 2 days and 2 weeks after drug administration. However, protein expression as determined by Western blot analysis did not change in either...

DOI: 10.1002/syn.20058 (opens in new tab) MDMA 5,7-dihydroxytryptamine Endocrinology Hippocampus +3

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.

Molecular Pharmacology June 2003 Vincent Setola, Sandra J Hufeisen, K Jane Grande-Allen et al.

Recent findings have implicated the 5-hydroxytryptamine 2B (5-HT2B) serotonin receptor in mediating the heart valve fibroplasia [valvular heart disease (VHD)] and primary pulmonary hypertension observed in patients taking the now-banned appetite suppressant fenfluramine (Pondimin, Redux). Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine...

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

Proceedings of the National Academy of Sciences September 3, 2002 Bryan L. Roth, Karen Baner, Richard B Westkaemper et al. 782 citations

Salvia divinorum, whose main active ingredient is the neoclerodane diterpene Salvinorin A, is a hallucinogenic plant in the mint family that has been used in traditional spiritual practices for its psychoactive properties by the Mazatecs of Oaxaca, Mexico. More recently, S. divinorum extracts and Salvinorin A have become more widely used in the U.S. as legal hallucinogens. We discovered that...

DOI: 10.1073/pnas.182234399 (opens in new tab) Full text (opens in new tab) Salvinorin a Natural compound Plant compound Kappa opioid receptor +9

In Vivo Neurobiological Effects of Ibogaine and Its O-Desmethyl Metabolite, 12-Hydroxyibogamine (Noribogaine), in Rats

Journal of Pharmacology and Experimental Therapeutics May 1, 2001 Michael H. Baumann, Richard B Rothman, John Pablo et al. 69 citations

Ibogaine is a naturally occurring compound with purported antiaddictive properties. When administered to primates, ibogaine is rapidly o-demethylated to form the metabolite 12-hydroxyibogamine (noribogaine). Peak blood levels of noribogaine exceed those of ibogaine, and noribogaine persists in the bloodstream for at least 1 day. Very few studies have systematically evaluated the neurobiological...

DOI: 10.1016/s0022-3565(24)29567-7 (opens in new tab) Serotonin Pharmacology Nucleus accumbens Microdialysis +7

Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine.

Annals of the New York Academy of Sciences September 1, 2000 Michael H. Baumann, John Pablo, S F Ali et al. 37 citations

Ibogaine (IBO) is a plant-derived alkaloid that is being evaluated as a possible medication for substance use disorders. When administered peripherally to monkeys and humans, IBO is rapidly converted to an o-demethylated metabolite, 12-hydroxyibogamine (NORIBO). We have found in rats that peak blood levels of NORIBO can exceed those of the parent compound, and NORIBO persists in the bloodstream...

DOI: 10.1111/j.1749-6632.2000.tb05210.x (opens in new tab) Full text (opens in new tab) Noribogaine Ibogaine metabolite Anti-addiction drug metabolite Addiction treatment +5

Comparative neurobiological effects of ibogaine and MK-801 in rats.

Drug and Alcohol Dependence May 1, 2000 Michael H. Baumann, Richard B Rothman, S F Ali 15 citations

Ibogaine is a plant-derived alkaloid with putative 'anti-addictive' properties. Although ibogaine binds to multiple targets in the brain, recent evidence suggests the drug acts as an N-methyl-D-aspartate (NMDA) antagonist similar to MK-801. The purpose of the present study was to compare neurochemical and neuroendocrine effects of ibogaine and MK-801 in vivo. Male rats received either i.p....

DOI: 10.1016/s0376-8716(99)00113-1 (opens in new tab) Full text (opens in new tab) Ibogaine Plant compound Anti-addiction compound Therapeutic compound +13

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Synapse 2000 Richard B Rothman, Michael H. Baumann, Christina M Dersch et al. 933 citations

A large body of evidence supports the hypothesis that mesolimbic dopamine (DA) mediates, in animal models, the reinforcing effects of central nervous system stimulants such as cocaine and amphetamine. The role DA plays in mediating amphetamine-type subjective effects of stimulants in humans remains to be established. Both amphetamine and cocaine increase norepinephrine (NE) via stimulation of...

Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison to MK-801.

Annals of the New York Academy of Sciences May 1, 1998 Michael H. Baumann, Richard B Rothman, Syed F. Ali 11 citations

Ibogaine (IBO) is a naturally-occurring indole compound that is being evaluated as a potential medication for substance use disorders. Although the precise mechanism of IBO action is unclear, recent in vitro data show this drug displays properties similar to the noncompetitive N-methyl-d-aspartate (NMDA) antagonist MK-801. The purpose of the present work was to compare In Vivo neurobiological...

DOI: 10.1111/j.1749-6632.1998.tb08240.x (opens in new tab) Full text (opens in new tab) Ibogaine: natural compound Ibogaine's effects Its action Mechanism +9

Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation.

Brain Research October 21, 1996 S F Ali, Glenn D. Newport, William Slikker et al. 29 citations

Ibogaine (IBO) is an indole alkaloid that is reported to facilitate drug abstinence in substance abusers. Despite considerable investigation, the mechanism of IBO action in vivo and its suitability as a treatment for drug addiction remains unclear. The present study was designed to evaluate the time-course effects of acute IBO on neuroendocrine and neurochemical indices. Adult male rats were...

Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.

Psychopharmacology September 1, 1996 J K Staley, Q Ouyang, John Pablo et al. 82 citations

The purported efficacy of ibogaine for the treatment of drug dependence may be due in part to an active metabolite. Ibogaine undergoes first pass metabolism and is O-demethylated to 12-hydroxyibogamine (12-OH ibogamine). Radioligand binding assays were conducted to identify the potency and selectivity profiles for ibogaine and 12-OH ibogamine. A comparison of 12-OH ibogamine to the primary...

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic mice

Synapse October 1, 1995 Jean Lud Cadet, Bruce Ladenheim, Hiroshi Hirata et al. 81 citations

Abstract The subacute and long‐term biochemical effects of methylenedioxymeth‐amphetamine (MDMA) were assessed in homozygous and heterozygous transgenic (Tg) mice that carry the complete sequence of the human copper‐zinc (CuZn) superoxide dismutase (SOD) gene. Non‐transgenic (Non‐Tg) mice showed significant decreased in striatal dopamine (DA) and dihydroxyphenylacetic acid (DOPAC) levels both...

DOI: 10.1002/syn.890210210 (opens in new tab) MDMA Superoxide dismutase Radical Pharmacology +3

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin.

Life Sciences 1995 Deborah C. Mash, J K Staley, Michael H. Baumann et al. 108 citations

Ibogaine is a hallucinogenic indole with putative efficacy for the treatment of cocaine, stimulant and opiate abuse. The purported efficacy of ibogaine following single dose administrations has led to the suggestion that a long-acting metabolite of ibogaine may explain in part how the drug reduces craving for psychostimulants and opiates. We report here that 12-hydroxyibogamine, a primary...

[3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex.

Synapse August 1, 1991 H C Akunne, A A Reid, A Thurkauf et al.

Previous work demonstrated two high-affinity PCP binding sites in guinea pig brain labeled by [3H]TCP (1-(1-[2-thienyl]cyclohexyl)piperidine): site 1 (N-methyl-D-aspartate [NMDA]-associated) and site 2 (dopamine-reuptake complex associated). The present study examined brain membranes prepared from various species, including human, for the presence of site 2, defined as binding in the presence...

Specificity of phencyclidine-like drugs and benzomorphan opiates for two high affinity phencyclidine binding sites in guinea pig brain.

Neuropharmacology September 1, 1990 A A Reid, M V Mattson, B R De Costa et al.

Recently, the presence of two high affinity binding sites for phencyclidine were described in guinea pig brain, with one site coupled to the glutamate excitatory amino acid receptor, specifically activated by N-methyl-D-aspartate (NMDA) (site 1) and the other site associated with the dopamine (DA) reuptake carrier (site 2). Phencyclidine and its analogs, as well as the benzomorphan opiates, are...

Pseudoallosteric modulation by (+)-MK801 of NMDA-coupled phencyclidine binding sites.

Life Sciences 1990 A A Reid, J A Monn, A E Jacobson et al.

Two high affinity phencyclidine (PCP) binding sites, labelled by [3H] 1-[1-(2-thienyl)cyclohexyl]piperidine ([3H]TCP), have been identified in guinea pig brain, with one site coupled to the N-methyl-D-aspartate (NMDA) receptor (site 1) and the other site associated with the dopamine reuptake carrier complex (site 2). In this study, PCP enhanced the dissociation of [3H]TCP from PCP site 1 and...